Misplaced Pages

Respimat

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Drug delivery device used for the treatment of respiratory conditions

Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Its developer, Boehringer Ingelheim, is currently conducting approved in the U.S. with a variety of their products, such as tiotropium and ipratropium/salbutamol. According to the manufacturer, the reusability of the inhaler reduces its carbon footprint by 71%.

References

  1. "First reusable, propellant-free inhaler launched to cut plastic waste". Pharmaceutical Journal. 17 September 2019. Retrieved 19 November 2019.

Sources

Routes of administration, dosage forms
Oral
Digestive tract (enteral)
Solids
Liquids
Oral mucosa (buccal, sublabial, sublingual)
Solids
Liquids
Respiratory tract (inhalation)
Solids
0
0
Liquids
Gas
Ophthalmic,
otic, nasal
Urogenital
  • Ointment
  • Pessary
  • Vaginal ring
  • Douche
  • Intrauterine device (IUD)
  • Extra-amniotic infusion
  • Intravesical infusion
  • Rectal (enteral)
    Dermal (topical)
  • Ointment
  • Topical cream
  • Topical gel
  • Liniment
  • Paste
  • Film
  • DMSO solution
  • Iontophoresis
  • Hydrogel
  • Liposomes
  • Transfersome vesicles
  • Cream
  • Lotion
  • Lip balm
  • Medicated shampoo
  • Dermal patch
  • Transdermal patch
  • Transdermal spray
  • Jet injector

  • (into tissue/blood)
    Skin (transdermal)
  • Intradermal
  • Subcutaneous
  • Transdermal implant
  • Organs
    Central nervous system
    Circulatory,
    musculoskeletal
    Stub icon

    This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

    Categories: